SlideShare a Scribd company logo
BIOASSAY
By :Dr. Sumit Kumar Mahato
Junior Resident( Academic)
Guide: Dr. Uma Shanker Pd. Keshri
Associate Professor
Department of Pharmacology
RIMS, Ranchi
 An assay is an investigative (analytic) procedure
in laboratory medicine, pharmacology,
environmental biology, and molecular
biology for qualitatively assessing or
quantitatively measuring the presence or
amount or the functional activity of a target
entity (the analyte) which can be
a drug or biochemical substance or
organic sample
 Chemical Assay
 Immunoassay
 Bioassay
Chemical Assay:
It is the study of the separation, identification,
and quantification of the chemical components of natural and
artificial materials.
Immunoassay:
A technique that makes use of the binding between an antigen
and its homologous antibody in order to identify and quantify the
specific antigen or antibody in a sample.
 Comparative assessment of relative potency of a test compound to a
standard compound on a living or biological tissue.
 Quantitative measurement of the amount of active principle or substance in
a pharmaceutical preparation or biological material using a suitable
biological system
Introduced by Paul Ehrlich - biostandardization of Diphtheria antitoxin
5
Bioassay
Bioassay
Chemical Assay
 Less Precise
 More time consuming
 More expensive
 Active constituent &
structure not known.
 More sensitive
 More men power
Required
 Difficult to handle
 More Precise
 Less time consuming
 Less expensive
 Active constituent &
structure fully
established.
 Less sensitive
 Less men power
required
 Easy to handle
7
Biological
assay
Bio
metrics
Biological
standadizatio
n
Bio-
standadizati
on
To compare the test substance with the
International Standard preparation of the same
To find out how much test substance is
required to produce the same biological effect,
as produced by the standard
Activity assayed should be the activity of
interest
8
Standard & test sample - similar pharmacological
effects & mode of action
Both should be compared for their established
pharmacological effect using specified technique
Ex: *Ach – contractile response on frog rectus
abdominis muscle
*Histamine – contractile response on guinea
pig ileum
9
 Problem of biological variation must be
minimized
 Experimental conditions - kept constant
 Animals - same species, sex and weight
 Number of animals - large enough to
minimize error (individual variation)
 Isolated preparations - sensitive
10
 No chemical method has been developed
 Chemical assay is too complex /not sensitive enough to
measure (ex: insulin, Ach)
 To measure the pharmacological activity of new or
chemically undefined substances
 For biological standardization of drugs obtained from
natural sources as these cannot be obtained in pure form.
Eg:
Oxytocin,Vasopressin,Insulin,Heparin..
11
 To compare the strength of a drug obtained
from various sources due to different
compositions
 Chemicals with similar structure, but different
biological activity
 Chemical structure of the active principle is
unknown
 Chemical structure known; cannot be actively
purified. Eg: Peptide hormones
12
 Sensitivity
 Specificity
 Repeatability
 Reproducibility
 Precision
 Accuracy
 Stability – tissue has to stay “bioassay-
fit
13
14
•Intact
animals
Invivo
•Isolated
tissues
Invitro
WHOLE ANIMALS
 Nor Adrenaline – Cat
 Cardiac Glycosides – Guinea Pig
 Insulin – Mice
 Estrogens – Ovariectamised Female Rat
ISOLATED TISSUE
 Acetyl Choline – Frog Rectus Abdominus muscle
 Histamine – Guinea Pig ileum
 Adrenaline – Rat uterus
 Oxytocin – Rat uterus oestrogen primed
15
Qualitative bioassay
Is used for assessing the physical effects of a substance that
may not be quantified, such as abnormal development or
deformity.
Eg: Arnold Adolph Berthold's famous experiment on castrated
chickens. This analysis found that by removing the testes of a
chicken, it would not develop into a rooster because the
endocrine signals necessary for this process were not available.
Quantitative bioassays
involve estimation of concentration/potency of a substance by
measurement of the biological response it produces. These
bioassays are typically analyzed using the methods of
biostatistics
1.Direct end point assay (DEPA)
2.Quantal assay (all or none assay)
3.Graded assay :
a) Bracketting assay
b) Matching assay
c) Interpolation assay
d) Multiple point assay ( 3-point, 4point, 6-
point, 8-point).
Principle: is to measure direct response of dose of standard and
test preparation. The threshold dose required for response is
determined for each experimental unit.
Ratio between these doses estimates the potency of the test
preparation relative to the standard.
Concentration of test= TDS/TDT×CSD
Where, TDS= Threshold dose of standard
TDT= Threshold dose of test
CSD= Concentration of standard drug
Threshold dose of standard = Total period of infusion × rate
of drug administration
Advantage:
 Drug effects appear rapidly and are easily recognised
 Drug effect is directly proportional to drug dose
 Rapid end-point detection.
Disadvantages:
 Only toxicity study or high dose study is possible
 Dose ranging study cannot be done
 Quantal response – the unknown is compared with the standard with
respect to potency which produces the quantal affect, i.e change is easily
recognised sign or often death.
 In a quantal assay there is use of dose response relationship.
 quantal response to a drug is obtained and percentage of positive
response at each dose is calculated.
 The response in quantal assay is varying, i.e some responses are
irreversible and hence animal used is once and some responses have no
permanent effect and animal can be used in next experiment
 e.g –
 Determination of LD50
 Hypoglycemic convulsion in mice in the assay of insulin
20
 Graded response - In these assays, as the dose
increases there is an equivalent rise in response.
The potency of a test agonist is determined by
comparing its mean response to standard mean
response.
 This process is also known as “analytical dilution
assay”
 GRA is the simplest way of determining potency of a
test drug because it does not require statistical
analysis
21
22
standard
Test/unknow
n
23
DRC & Log DRC
30%
70%
Sigmoid curve
Wide range of doses
can plot
 Rectangular hyperbola
• Potency
• Efficacy
• Slope of curve
24
 Used when test sample is too small.
 Comparison of potency between unknown and standard drug is done
by trial and error method.
 Response is matched at only one dose
 Does not need dose respone curve of test compound
 It require most sensitive tissue
 Concentration of test= (Dose of standard/ Dose of test)× conc. Of standard
 Disadvantage:
 Experimental error is not excluded out
 There is no sign of parallelism as it lack dose response relationship.
 Used when test sample is too small.
 Single or few responses is taken by using any test drug
concentration.
 This response is bracketed between two responses one
higher and one lower of the standard drug.
 The strength of the unknown can be found by simple
interpolation of this bracketted response on dose axis
28
 less accurate,time consuming, troublesome
 cannot get exact match of response
 quantitative difference b/w test & standard not
obtained
30
standard
Test/unknow
n
 A log dose-response curve is plotted with the standard,
 Single or few responses of test drug are plotted.
 The dose of test drug which comes at the linear log dose-
response is interpolated from the dose respone plot
31
100
50
0 x x1
standard
%
R
E
S
P
O
N
S
E
LOG DOSE
 Sensitivity of tissue is 1st determined by prior
plotting of a conc-response curve with known
agonist
 Dose can be plotted even if it varies over
thousand fold range
 Error is normally distributed
 Sensitivity of tissue changes with time
 Timing of doses not taken into account
 Variation in mode of application of drugs
 Responses are repeated several times and the
mean of each is taken
 Chances of error are minimized
 3 point method - 2 doses of std+1 dose of test
 4 point method - 2 doses of std+2 doses of test
 6 point method - 3 doses of std+3 doses of test
 Latin square method of randomization to avoid
any bias
35
36
t s1 s2
s1 s2 t
s2 t s1
3
cycles
37
%
R
E
S
P
O
N
S
E
LOG DOSE
s1
T
t
S2
s2
S1
s1 s2 t
t s1 s2
s2 s1 t
t s2 s1
• Mean responses of these 3 sets plotted
• Log potency ratio (M) =
(T-S1÷ S2-S1)× log d
where, d – dose ratio = s2/s1
• Strength of unknown = s1/t × antilog of M
S1, S2- length of standard dose response selected between
25-75%
T-length of test dose response selected in between of
two standard responses
s2/s1 -standard drug dose which came in contact with tissueand
given the response S1, S2. respectively
t = Test drug dose which came in contact with tissu and given the
response T
39
41
4 - POINT ASSAY
42
%
R
E
S
P
O
N
S
E
LOG DOSE
s1
T1
t1
S2
s2
S1
T2
t2
s2 t1 t2 s1
t1 t2 s1 s2
t2 s1 s2 t1
s1 s2 t1 t2
• Mean responses of 4 sets plotted
• Log potency ratio (M)
(T2-S2)+(T1-S1) × Log d
(S2-S1)+(T2-T1)
where, d-dose ratio = s2/s1
• Strength of unknown =
s1/t1 × antilog of M
44
 3+3 dose assay
 3 conc each of std & test drug are used
 6 sets of experiments using 6 doses in each
set
 More time consuming,lesser in use
 Reliability is excellent
 to measure the pharmacological activity of new/
chemically undefined substances
 to investigate the function of endogenous
mediators
 to measure drug toxicity and unwanted effects
 to measure the conc of drugs and other active
substances in the blood or other body fluids
47
 Determination of potency, ED50/LD50 of
drugs
 New drug development
 Measure clinical effectiveness
48
• Biological variation
• Troublesome
• Time consuming
• Expensive
• Less accurate than physico-chemical
methods
49
 Successful tool in estimation & discovery of
biologically active substances
 Sensitivity & Specificity – important tool in
pharmacology
bioassay.pdf

More Related Content

Similar to bioassay.pdf

Concept of bioassays by jayu
Concept of bioassays by jayuConcept of bioassays by jayu
Concept of bioassays by jayu
JayeshRajput7
 
Bioassay
BioassayBioassay
Bioassay
My_VivJaan
 
Bioassays praveen tk
Bioassays praveen tkBioassays praveen tk
Bioassays praveen tk
Praveen Krishnamurthy
 
BIOASSAY PPT (DEEPRAJ SINGH RAUTELA).pptx
BIOASSAY PPT (DEEPRAJ SINGH RAUTELA).pptxBIOASSAY PPT (DEEPRAJ SINGH RAUTELA).pptx
BIOASSAY PPT (DEEPRAJ SINGH RAUTELA).pptx
Deeprajrautela
 
Bioassay ,its types for theory & practical
Bioassay ,its types for theory & practicalBioassay ,its types for theory & practical
Bioassay ,its types for theory & practical
Heena Parveen
 
Expt. 3 Introduction to principles of bioassay, its types including advantage...
Expt. 3 Introduction to principles of bioassay, its types including advantage...Expt. 3 Introduction to principles of bioassay, its types including advantage...
Expt. 3 Introduction to principles of bioassay, its types including advantage...
VISHALJADHAV100
 
Bioassay techniques
Bioassay techniquesBioassay techniques
Bioassaytechniques 150116070330-conversion-gate01
Bioassaytechniques 150116070330-conversion-gate01Bioassaytechniques 150116070330-conversion-gate01
Bioassaytechniques 150116070330-conversion-gate01
RDAIDIFITRINAKHIROTD1
 
Bioassay go
Bioassay goBioassay go
Bioassay go
BBAU LUCKNOW GOVIND
 
Bioassay
BioassayBioassay
Bioassay
GOVIND YADAV
 
bioassaytechniques-.ppt
bioassaytechniques-.pptbioassaytechniques-.ppt
bioassaytechniques-.ppt
GAMPA kumar
 
bioassaytechniques-.ppt
bioassaytechniques-.pptbioassaytechniques-.ppt
bioassaytechniques-.ppt
GAMPA kumar
 
Biological assay, drug assay, Bioassay of Insulin
Biological assay, drug assay, Bioassay of InsulinBiological assay, drug assay, Bioassay of Insulin
Biological assay, drug assay, Bioassay of Insulin
PradyumnaGhosal
 
Bioassay Techniques.......
Bioassay Techniques.......Bioassay Techniques.......
Bioassay Techniques.......
Suvarta Maru
 
To perform Analytical method validation of Paracetamol and Ibuprofen in pure ...
To perform Analytical method validation of Paracetamol and Ibuprofen in pure ...To perform Analytical method validation of Paracetamol and Ibuprofen in pure ...
To perform Analytical method validation of Paracetamol and Ibuprofen in pure ...
Aakashdeep Raval
 
Extrapolation.pptx
Extrapolation.pptxExtrapolation.pptx
Extrapolation.pptx
Sushobhan Roy
 
Expt 3 Bracketing bioassay
Expt 3 Bracketing bioassayExpt 3 Bracketing bioassay
Expt 3 Bracketing bioassay
MirzaAnwarBaig1
 
Biological Assay .pdf
Biological Assay .pdfBiological Assay .pdf
Biological Assay .pdf
UVAS
 
Bio assay
Bio assayBio assay
Notes Ch13
Notes Ch13Notes Ch13
Notes Ch13jmalpass
 

Similar to bioassay.pdf (20)

Concept of bioassays by jayu
Concept of bioassays by jayuConcept of bioassays by jayu
Concept of bioassays by jayu
 
Bioassay
BioassayBioassay
Bioassay
 
Bioassays praveen tk
Bioassays praveen tkBioassays praveen tk
Bioassays praveen tk
 
BIOASSAY PPT (DEEPRAJ SINGH RAUTELA).pptx
BIOASSAY PPT (DEEPRAJ SINGH RAUTELA).pptxBIOASSAY PPT (DEEPRAJ SINGH RAUTELA).pptx
BIOASSAY PPT (DEEPRAJ SINGH RAUTELA).pptx
 
Bioassay ,its types for theory & practical
Bioassay ,its types for theory & practicalBioassay ,its types for theory & practical
Bioassay ,its types for theory & practical
 
Expt. 3 Introduction to principles of bioassay, its types including advantage...
Expt. 3 Introduction to principles of bioassay, its types including advantage...Expt. 3 Introduction to principles of bioassay, its types including advantage...
Expt. 3 Introduction to principles of bioassay, its types including advantage...
 
Bioassay techniques
Bioassay techniquesBioassay techniques
Bioassay techniques
 
Bioassaytechniques 150116070330-conversion-gate01
Bioassaytechniques 150116070330-conversion-gate01Bioassaytechniques 150116070330-conversion-gate01
Bioassaytechniques 150116070330-conversion-gate01
 
Bioassay go
Bioassay goBioassay go
Bioassay go
 
Bioassay
BioassayBioassay
Bioassay
 
bioassaytechniques-.ppt
bioassaytechniques-.pptbioassaytechniques-.ppt
bioassaytechniques-.ppt
 
bioassaytechniques-.ppt
bioassaytechniques-.pptbioassaytechniques-.ppt
bioassaytechniques-.ppt
 
Biological assay, drug assay, Bioassay of Insulin
Biological assay, drug assay, Bioassay of InsulinBiological assay, drug assay, Bioassay of Insulin
Biological assay, drug assay, Bioassay of Insulin
 
Bioassay Techniques.......
Bioassay Techniques.......Bioassay Techniques.......
Bioassay Techniques.......
 
To perform Analytical method validation of Paracetamol and Ibuprofen in pure ...
To perform Analytical method validation of Paracetamol and Ibuprofen in pure ...To perform Analytical method validation of Paracetamol and Ibuprofen in pure ...
To perform Analytical method validation of Paracetamol and Ibuprofen in pure ...
 
Extrapolation.pptx
Extrapolation.pptxExtrapolation.pptx
Extrapolation.pptx
 
Expt 3 Bracketing bioassay
Expt 3 Bracketing bioassayExpt 3 Bracketing bioassay
Expt 3 Bracketing bioassay
 
Biological Assay .pdf
Biological Assay .pdfBiological Assay .pdf
Biological Assay .pdf
 
Bio assay
Bio assayBio assay
Bio assay
 
Notes Ch13
Notes Ch13Notes Ch13
Notes Ch13
 

More from ChijiokeNsofor

BTC 509 Intersection of AI and Biotechnolog.pptx
BTC 509 Intersection of AI and Biotechnolog.pptxBTC 509 Intersection of AI and Biotechnolog.pptx
BTC 509 Intersection of AI and Biotechnolog.pptx
ChijiokeNsofor
 
BTC 810 Mass spectrometry and it applications.ppt
BTC 810 Mass spectrometry and it applications.pptBTC 810 Mass spectrometry and it applications.ppt
BTC 810 Mass spectrometry and it applications.ppt
ChijiokeNsofor
 
Work Report- October 2021.pptx
Work Report- October 2021.pptxWork Report- October 2021.pptx
Work Report- October 2021.pptx
ChijiokeNsofor
 
FRS 310 Bite mark evidence.ppt
FRS 310 Bite mark evidence.pptFRS 310 Bite mark evidence.ppt
FRS 310 Bite mark evidence.ppt
ChijiokeNsofor
 
Project Report.pptx
Project Report.pptxProject Report.pptx
Project Report.pptx
ChijiokeNsofor
 
cells of immune system.ppt
cells of immune system.pptcells of immune system.ppt
cells of immune system.ppt
ChijiokeNsofor
 
FRS 301 Analysis of biological fluids.pptx
FRS 301 Analysis of biological fluids.pptxFRS 301 Analysis of biological fluids.pptx
FRS 301 Analysis of biological fluids.pptx
ChijiokeNsofor
 
BTC 810 Analysis of Transcriptomes.pptx
BTC 810 Analysis of Transcriptomes.pptxBTC 810 Analysis of Transcriptomes.pptx
BTC 810 Analysis of Transcriptomes.pptx
ChijiokeNsofor
 
FRS 411-POST MORTEM CHANGES.ppt
FRS 411-POST MORTEM CHANGES.pptFRS 411-POST MORTEM CHANGES.ppt
FRS 411-POST MORTEM CHANGES.ppt
ChijiokeNsofor
 
FRS 411-Death.pptx
FRS 411-Death.pptxFRS 411-Death.pptx
FRS 411-Death.pptx
ChijiokeNsofor
 
FRS 310 Bite mark.pptx
FRS 310 Bite mark.pptxFRS 310 Bite mark.pptx
FRS 310 Bite mark.pptx
ChijiokeNsofor
 
antibody engineering.ppt
antibody engineering.pptantibody engineering.ppt
antibody engineering.ppt
ChijiokeNsofor
 
BTC 506 Phylogenetic Tree.pptx
BTC 506 Phylogenetic Tree.pptxBTC 506 Phylogenetic Tree.pptx
BTC 506 Phylogenetic Tree.pptx
ChijiokeNsofor
 
FRS 304 Forensic Anthropology-Introduction.pptx
FRS 304 Forensic Anthropology-Introduction.pptxFRS 304 Forensic Anthropology-Introduction.pptx
FRS 304 Forensic Anthropology-Introduction.pptx
ChijiokeNsofor
 
cells of immune system.ppt
cells of immune system.pptcells of immune system.ppt
cells of immune system.ppt
ChijiokeNsofor
 
BTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptx
BTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptxBTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptx
BTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptx
ChijiokeNsofor
 
BTC 506 Phylogenetic Analysis.pptx
BTC 506 Phylogenetic Analysis.pptxBTC 506 Phylogenetic Analysis.pptx
BTC 506 Phylogenetic Analysis.pptx
ChijiokeNsofor
 
cancer prevention.pptx
cancer prevention.pptxcancer prevention.pptx
cancer prevention.pptx
ChijiokeNsofor
 
bacterial genome organization.pptx
bacterial genome organization.pptxbacterial genome organization.pptx
bacterial genome organization.pptx
ChijiokeNsofor
 
6238578.ppt
6238578.ppt6238578.ppt
6238578.ppt
ChijiokeNsofor
 

More from ChijiokeNsofor (20)

BTC 509 Intersection of AI and Biotechnolog.pptx
BTC 509 Intersection of AI and Biotechnolog.pptxBTC 509 Intersection of AI and Biotechnolog.pptx
BTC 509 Intersection of AI and Biotechnolog.pptx
 
BTC 810 Mass spectrometry and it applications.ppt
BTC 810 Mass spectrometry and it applications.pptBTC 810 Mass spectrometry and it applications.ppt
BTC 810 Mass spectrometry and it applications.ppt
 
Work Report- October 2021.pptx
Work Report- October 2021.pptxWork Report- October 2021.pptx
Work Report- October 2021.pptx
 
FRS 310 Bite mark evidence.ppt
FRS 310 Bite mark evidence.pptFRS 310 Bite mark evidence.ppt
FRS 310 Bite mark evidence.ppt
 
Project Report.pptx
Project Report.pptxProject Report.pptx
Project Report.pptx
 
cells of immune system.ppt
cells of immune system.pptcells of immune system.ppt
cells of immune system.ppt
 
FRS 301 Analysis of biological fluids.pptx
FRS 301 Analysis of biological fluids.pptxFRS 301 Analysis of biological fluids.pptx
FRS 301 Analysis of biological fluids.pptx
 
BTC 810 Analysis of Transcriptomes.pptx
BTC 810 Analysis of Transcriptomes.pptxBTC 810 Analysis of Transcriptomes.pptx
BTC 810 Analysis of Transcriptomes.pptx
 
FRS 411-POST MORTEM CHANGES.ppt
FRS 411-POST MORTEM CHANGES.pptFRS 411-POST MORTEM CHANGES.ppt
FRS 411-POST MORTEM CHANGES.ppt
 
FRS 411-Death.pptx
FRS 411-Death.pptxFRS 411-Death.pptx
FRS 411-Death.pptx
 
FRS 310 Bite mark.pptx
FRS 310 Bite mark.pptxFRS 310 Bite mark.pptx
FRS 310 Bite mark.pptx
 
antibody engineering.ppt
antibody engineering.pptantibody engineering.ppt
antibody engineering.ppt
 
BTC 506 Phylogenetic Tree.pptx
BTC 506 Phylogenetic Tree.pptxBTC 506 Phylogenetic Tree.pptx
BTC 506 Phylogenetic Tree.pptx
 
FRS 304 Forensic Anthropology-Introduction.pptx
FRS 304 Forensic Anthropology-Introduction.pptxFRS 304 Forensic Anthropology-Introduction.pptx
FRS 304 Forensic Anthropology-Introduction.pptx
 
cells of immune system.ppt
cells of immune system.pptcells of immune system.ppt
cells of immune system.ppt
 
BTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptx
BTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptxBTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptx
BTC 506 Gene Identification using Bioinformatic Tools-230302130331.pptx
 
BTC 506 Phylogenetic Analysis.pptx
BTC 506 Phylogenetic Analysis.pptxBTC 506 Phylogenetic Analysis.pptx
BTC 506 Phylogenetic Analysis.pptx
 
cancer prevention.pptx
cancer prevention.pptxcancer prevention.pptx
cancer prevention.pptx
 
bacterial genome organization.pptx
bacterial genome organization.pptxbacterial genome organization.pptx
bacterial genome organization.pptx
 
6238578.ppt
6238578.ppt6238578.ppt
6238578.ppt
 

Recently uploaded

Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 

Recently uploaded (20)

Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 

bioassay.pdf

  • 1. BIOASSAY By :Dr. Sumit Kumar Mahato Junior Resident( Academic) Guide: Dr. Uma Shanker Pd. Keshri Associate Professor Department of Pharmacology RIMS, Ranchi
  • 2.  An assay is an investigative (analytic) procedure in laboratory medicine, pharmacology, environmental biology, and molecular biology for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity (the analyte) which can be a drug or biochemical substance or organic sample
  • 3.  Chemical Assay  Immunoassay  Bioassay
  • 4. Chemical Assay: It is the study of the separation, identification, and quantification of the chemical components of natural and artificial materials. Immunoassay: A technique that makes use of the binding between an antigen and its homologous antibody in order to identify and quantify the specific antigen or antibody in a sample.
  • 5.  Comparative assessment of relative potency of a test compound to a standard compound on a living or biological tissue.  Quantitative measurement of the amount of active principle or substance in a pharmaceutical preparation or biological material using a suitable biological system Introduced by Paul Ehrlich - biostandardization of Diphtheria antitoxin 5
  • 6. Bioassay Bioassay Chemical Assay  Less Precise  More time consuming  More expensive  Active constituent & structure not known.  More sensitive  More men power Required  Difficult to handle  More Precise  Less time consuming  Less expensive  Active constituent & structure fully established.  Less sensitive  Less men power required  Easy to handle
  • 8. To compare the test substance with the International Standard preparation of the same To find out how much test substance is required to produce the same biological effect, as produced by the standard Activity assayed should be the activity of interest 8
  • 9. Standard & test sample - similar pharmacological effects & mode of action Both should be compared for their established pharmacological effect using specified technique Ex: *Ach – contractile response on frog rectus abdominis muscle *Histamine – contractile response on guinea pig ileum 9
  • 10.  Problem of biological variation must be minimized  Experimental conditions - kept constant  Animals - same species, sex and weight  Number of animals - large enough to minimize error (individual variation)  Isolated preparations - sensitive 10
  • 11.  No chemical method has been developed  Chemical assay is too complex /not sensitive enough to measure (ex: insulin, Ach)  To measure the pharmacological activity of new or chemically undefined substances  For biological standardization of drugs obtained from natural sources as these cannot be obtained in pure form. Eg: Oxytocin,Vasopressin,Insulin,Heparin.. 11
  • 12.  To compare the strength of a drug obtained from various sources due to different compositions  Chemicals with similar structure, but different biological activity  Chemical structure of the active principle is unknown  Chemical structure known; cannot be actively purified. Eg: Peptide hormones 12
  • 13.  Sensitivity  Specificity  Repeatability  Reproducibility  Precision  Accuracy  Stability – tissue has to stay “bioassay- fit 13
  • 15. WHOLE ANIMALS  Nor Adrenaline – Cat  Cardiac Glycosides – Guinea Pig  Insulin – Mice  Estrogens – Ovariectamised Female Rat ISOLATED TISSUE  Acetyl Choline – Frog Rectus Abdominus muscle  Histamine – Guinea Pig ileum  Adrenaline – Rat uterus  Oxytocin – Rat uterus oestrogen primed 15
  • 16. Qualitative bioassay Is used for assessing the physical effects of a substance that may not be quantified, such as abnormal development or deformity. Eg: Arnold Adolph Berthold's famous experiment on castrated chickens. This analysis found that by removing the testes of a chicken, it would not develop into a rooster because the endocrine signals necessary for this process were not available. Quantitative bioassays involve estimation of concentration/potency of a substance by measurement of the biological response it produces. These bioassays are typically analyzed using the methods of biostatistics
  • 17. 1.Direct end point assay (DEPA) 2.Quantal assay (all or none assay) 3.Graded assay : a) Bracketting assay b) Matching assay c) Interpolation assay d) Multiple point assay ( 3-point, 4point, 6- point, 8-point).
  • 18. Principle: is to measure direct response of dose of standard and test preparation. The threshold dose required for response is determined for each experimental unit. Ratio between these doses estimates the potency of the test preparation relative to the standard. Concentration of test= TDS/TDT×CSD Where, TDS= Threshold dose of standard TDT= Threshold dose of test CSD= Concentration of standard drug Threshold dose of standard = Total period of infusion × rate of drug administration
  • 19. Advantage:  Drug effects appear rapidly and are easily recognised  Drug effect is directly proportional to drug dose  Rapid end-point detection. Disadvantages:  Only toxicity study or high dose study is possible  Dose ranging study cannot be done
  • 20.  Quantal response – the unknown is compared with the standard with respect to potency which produces the quantal affect, i.e change is easily recognised sign or often death.  In a quantal assay there is use of dose response relationship.  quantal response to a drug is obtained and percentage of positive response at each dose is calculated.  The response in quantal assay is varying, i.e some responses are irreversible and hence animal used is once and some responses have no permanent effect and animal can be used in next experiment  e.g –  Determination of LD50  Hypoglycemic convulsion in mice in the assay of insulin 20
  • 21.  Graded response - In these assays, as the dose increases there is an equivalent rise in response. The potency of a test agonist is determined by comparing its mean response to standard mean response.  This process is also known as “analytical dilution assay”  GRA is the simplest way of determining potency of a test drug because it does not require statistical analysis 21
  • 23. 23 DRC & Log DRC 30% 70% Sigmoid curve Wide range of doses can plot  Rectangular hyperbola • Potency • Efficacy • Slope of curve
  • 24. 24
  • 25.  Used when test sample is too small.  Comparison of potency between unknown and standard drug is done by trial and error method.  Response is matched at only one dose  Does not need dose respone curve of test compound  It require most sensitive tissue  Concentration of test= (Dose of standard/ Dose of test)× conc. Of standard  Disadvantage:  Experimental error is not excluded out  There is no sign of parallelism as it lack dose response relationship.
  • 26.  Used when test sample is too small.  Single or few responses is taken by using any test drug concentration.  This response is bracketed between two responses one higher and one lower of the standard drug.  The strength of the unknown can be found by simple interpolation of this bracketted response on dose axis
  • 27.
  • 28. 28
  • 29.  less accurate,time consuming, troublesome  cannot get exact match of response  quantitative difference b/w test & standard not obtained
  • 31.  A log dose-response curve is plotted with the standard,  Single or few responses of test drug are plotted.  The dose of test drug which comes at the linear log dose- response is interpolated from the dose respone plot 31
  • 33.  Sensitivity of tissue is 1st determined by prior plotting of a conc-response curve with known agonist  Dose can be plotted even if it varies over thousand fold range  Error is normally distributed
  • 34.  Sensitivity of tissue changes with time  Timing of doses not taken into account  Variation in mode of application of drugs
  • 35.  Responses are repeated several times and the mean of each is taken  Chances of error are minimized  3 point method - 2 doses of std+1 dose of test  4 point method - 2 doses of std+2 doses of test  6 point method - 3 doses of std+3 doses of test  Latin square method of randomization to avoid any bias 35
  • 36. 36 t s1 s2 s1 s2 t s2 t s1 3 cycles
  • 38. s1 s2 t t s1 s2 s2 s1 t t s2 s1
  • 39. • Mean responses of these 3 sets plotted • Log potency ratio (M) = (T-S1÷ S2-S1)× log d where, d – dose ratio = s2/s1 • Strength of unknown = s1/t × antilog of M S1, S2- length of standard dose response selected between 25-75% T-length of test dose response selected in between of two standard responses s2/s1 -standard drug dose which came in contact with tissueand given the response S1, S2. respectively t = Test drug dose which came in contact with tissu and given the response T 39
  • 40.
  • 41. 41 4 - POINT ASSAY
  • 43. s2 t1 t2 s1 t1 t2 s1 s2 t2 s1 s2 t1 s1 s2 t1 t2
  • 44. • Mean responses of 4 sets plotted • Log potency ratio (M) (T2-S2)+(T1-S1) × Log d (S2-S1)+(T2-T1) where, d-dose ratio = s2/s1 • Strength of unknown = s1/t1 × antilog of M 44
  • 45.
  • 46.  3+3 dose assay  3 conc each of std & test drug are used  6 sets of experiments using 6 doses in each set  More time consuming,lesser in use  Reliability is excellent
  • 47.  to measure the pharmacological activity of new/ chemically undefined substances  to investigate the function of endogenous mediators  to measure drug toxicity and unwanted effects  to measure the conc of drugs and other active substances in the blood or other body fluids 47
  • 48.  Determination of potency, ED50/LD50 of drugs  New drug development  Measure clinical effectiveness 48
  • 49. • Biological variation • Troublesome • Time consuming • Expensive • Less accurate than physico-chemical methods 49
  • 50.  Successful tool in estimation & discovery of biologically active substances  Sensitivity & Specificity – important tool in pharmacology